TriSalus Life Sciences (NASDAQ:TLSIW) Stock Price Crosses Above Fifty Day Moving Average – What’s Next?

TriSalus Life Sciences, Inc. (NASDAQ:TLSIW) crossed above its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $0.87 and traded as high as $0.9357. TriSalus Life Sciences shares last traded at $0.9290, with a volume of 1,826 shares.

TriSalus Life Sciences Stock Performance

The business’s 50 day simple moving average is $0.87 and its 200 day simple moving average is $0.96.

Institutional Investors Weigh In On TriSalus Life Sciences

A hedge fund recently bought a new stake in TriSalus Life Sciences stock. State Street Corp acquired a new position in TriSalus Life Sciences, Inc. (NASDAQ:TLSIW) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 610,963 shares of the company’s stock, valued at approximately $2,780,000.

TriSalus Life Sciences Company Profile

TriSalus Life Sciences is a medical technology and therapeutics company focused on improving treatment delivery for patients with solid tumors, particularly tumors in the liver and pancreas. Its approach combines proprietary drug-delivery technology with the development of immunotherapies. The company’s TriNav® infusion system is designed to deliver therapies into tumors using its Pressure-Enabled Drug Delivery (PEDD) approach. TriSalus is also developing investigational therapies intended to work alongside its delivery platform; these therapies are not established treatments.